Public consultation on the interim decision to amend the Poisons Standard in relation to adrenaline - ACMS, June 2025

Feedback updated 28 Jan 2026

We asked

From 19 December 2025 to 12 January 2026, we sought submissions from the public on the Delegate’s interim decisions on adrenaline previously discussed at the June 2025 meetings of the Advisory Committees on Medicines Scheduling. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written submission.

You said

A total of 4 submissions were received through the consultation, all from organisations. Of the submissions, 3 were in full support, and 1 was in partially support of the interim decision. All submission included written justifications.

We did

The Delegate considered all submissions prior to making the final decision. The final decision on the proposed amendment to the Poisons Standard was published on 22 January 2026.

Published responses

View submitted responses where consent has been given to publish the response.

Closed 12 Jan 2026

Opened 19 Dec 2025

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Overview

Interim decision on proposed amendments to the Poisons Standard in relation to adrenaline. 

This consultation is for an interim decision made in relation to adrenaline that was discussed at the JUNE 2025 meetings of the Advisory Committee on Medicines Scheduling (ACMS).

Kindly note that the interim decision published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 12 JANUARY 2026. All submissions received by the deadline will be considered by the delegate before they make a final decision.

The interim decision under consultation are detailed in the Public notice of the interim decision in relation to adrenaline which can be accessed here.

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions at a later date.

Audiences

  • Aboriginal and Torres Strait Islander People
  • Academics
  • Aged care professionals
  • Aged care service providers
  • Aged care workforce
  • Biologicals
  • BPRU staff
  • Businesses
  • Carers and guardians
  • Commonwealth agencies
  • Community groups
  • Complementary medicines
  • Contracted Service Providers
  • Families
  • General public
  • Graduates
  • Health professionals
  • Health staff
  • Health workforce
  • HPRG (TGA) Staff
  • Medical Devices & IVDs
  • Men
  • Non-government organisations
  • Online and Publications staff
  • Other
  • Over-the-counter medicines
  • Parents
  • PCCD
  • Prescription medicines
  • Secretariat
  • Seniors
  • State government agencies
  • Women
  • Young people